Silver in health care: Antimicrobial effects and safety in use

Current Problems in Dermatology

Volumn 33, Issue , 2006, Pages 17-34

  Lansdown, Alan B G ^a,b  

^a CHARING CROSS HOSPITAL   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; SILVER; SILVER NITRATE; SULFADIAZINE;

HUMAN; INJURY; INTRADERMAL DRUG ADMINISTRATION; REVIEW; SKIN; SKIN CARE; TEXTILE; WOUND HEALING;

ADMINISTRATION, CUTANEOUS; ANTI-INFECTIVE AGENTS; HUMANS; SILVER; SILVER NITRATE; SKIN; SKIN CARE; SULFADIAZINE; TEXTILES; WOUND HEALING;

EID: 33750096683     PISSN: 14215721     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000093928     Document Type: Review

References (24)

1. White RJ: An historical overview of the use of silver in wound management. J Care 2003;13:1-8.
2. Credé KSF: Die Verhütung der Augenentzündung der Neugeborenen, der häufigsten und wichtigsten Ursache der Blindheit. Berlin, Hirschwald, 1895.
3. Munch R: Robert Koch. Microbes Infect 2003;5:69-74.
4. Halstead WS: The operative treatment of hernia. Am J Med Sci 1895;110:13-17.
5. Sollemann T: A Manual of Pharmacology. Philadelphia, Saunders, 1942, pp 1102-1109.
6. Clarke AJ: General pharmacology; in Heffter A (ed): Handbuch der experimentellen Pharmacologie: Ergänzung. Springer, Berlin, 1937, p 4.
7. Lansdown ABG: A review of the use of silver in wound dressings: facts and fallacies. Br J Nurs 2004;13(suppl):S6-S13.
8. Lansdown ABG: Silver: its antibacterial properties and mechanism of action. J Wound Care 2002;11:125-131.
9. Fox CL: Silver sulphadiazine: a new topical therapy for Pseudomonas aeruginosa in burns. Arch Surg 1968;96:184-188.
10. Lowbury EJ: Problems of resistance in open wounds and burns; in Mouton RP, Brumfitt W, Hamilton Miller JMT (eds): The Rational Choice of Antibacterial Agents. Harrap Handbooks. London, Kluwer, 1977, pp 18-31.
11. Lansdown ABG: Silver in wound care and management; in Stephen-Haynes J (ed): Wound Care Society Educational Supplement. Wound Care Society, 2003, vol 1, No 3.
12. Hipler C, Elsner P, Fluhr JW: New silver-coated cellulose fibres: in vitro investigations into antibacterial and antimycotic activity. 2nd Eur Conf Textiles Skin, Stuttgart, 2004, No 5-1-29.
13. Becker RO, Spadaro JA: Treatment of orthopaedic infections with electrically generated silver ions: a preliminary report. J Bone Joint Surg 1978;60:871-881.
14. Lansdown ABG, Williams A: How safe is silver in wound care? J Wound Care 2004;13:131-136.
15. Wang XW, Wang NZ, Zhang OZ: Tissue deposition of silver following topical use of silver sulphadiazine in extensive burns. Burns Incl Therm Inj 1985;11:197-201.
16. Boosalis MG, McCall JT, Ahrenholz DH: Serum and urinary silver levels in thermal injury patients. Surgery 1987;101:40-43.
17. Lansdown ABG, Jensen K, Jensen MQ: Contreet foam and contreet hydrocolloid: an insight into two new silver-containing dressings. J Wound Care 2003;12:205-210.
18. Enoch S, Harding KG: Wound bed preparation: the science behind the removal of barriers to healing. Wounds 2003;15:213-229.
19. Coombs CJ, Wan AT, Masterton JP: Do burns patients have a silver lining? Burns Incl Therm Inj 1992;18:179-184.
20. Lansdown ABG, Williams A, Chandler S, Benfield S: Silver absorption and antibacterial efficacy of silver dressings. J Wound Care 2005;14:155-160.
21. Lansdown ABG, Myers S, Clarke J, O'Sullivan P: A reappraisal of the role of cerium in burn wound management. J Wound Care 2003;12:113-118.
22. Elliott T: Role of antimicrobial central venous catheters for the prevention of associated infections. J Antimicrob Chemother 1999;43:441-446.
23. Darouiche RO: Anti-infective efficacy of silver-coated medical prostheses. Clin Infect Dis 1999;29:1371-1377.
24. Saint S, Veenstra RH, Sullivan SD: The potential clinical and economic benefits of silver alloy urinary catheters in preventing urinary tract infection. Arch Intern Med 2000;160:2670-2673.